Stock 4671 FALCO HOLDINGS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials FALCO HOLDINGS Co., Ltd.

Equities

4671

JP3802650006

Healthcare Facilities & Services

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-04-26 am EDT 		5-day change 1st Jan Change
2,231 JPY -0.62% Intraday chart for FALCO HOLDINGS Co., Ltd. +2.76% +6.85%
Jan. 30 Tranche Update on FALCO HOLDINGS Co., Ltd.'s Equity Buyback Plan announced on August 10, 2023. CI
Jan. 29 FALCO HOLDINGS Co., Ltd.'s Equity Buyback announced on August 10, 2023, has closed with 587,500 shares, representing 5.29% for ¥1,199.88 million. CI

Valuation

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 14,890 18,686 18,131 20,974 20,617 23,811 - -
Enterprise Value (EV) 1 9,558 14,923 12,417 14,399 10,815 14,214 14,161 13,988
P/E ratio 22.7 x 15.2 x 9.79 x 5.92 x 9.13 x 14.6 x 15.8 x 14.6 x
Yield 3.38% 2.71% 3.09% 3.19% 5.09% 5.15% 5.38% 5.47%
Capitalization / Revenue 0.34 x 0.43 x 0.42 x 0.42 x 0.44 x 0.55 x 0.55 x 0.54 x
EV / Revenue 0.22 x 0.35 x 0.28 x 0.29 x 0.23 x 0.33 x 0.33 x 0.32 x
EV / EBITDA 4.41 x 8.44 x 3.48 x 2.23 x 2.63 x 4.49 x 4.21 x 3.92 x
EV / FCF 36.5 x -44.7 x 8.64 x - 12.4 x 9.61 x 11.4 x 10.2 x
FCF Yield 2.74% -2.24% 11.6% - 8.09% 10.4% 8.74% 9.79%
Price to Book 0.79 x 1 x 0.89 x 0.9 x 0.83 x 0.91 x 0.91 x 0.89 x
Nbr of stocks (in thousands) 10,948 10,551 10,367 10,451 10,487 10,673 - -
Reference price 2 1,360 1,771 1,749 2,007 1,966 2,231 2,231 2,231
Announcement Date 5/10/19 5/12/20 5/11/21 5/13/22 5/12/23 - - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 44,156 43,185 43,608 50,007 46,913 43,000 43,500 44,000
EBITDA 1 2,165 1,768 3,567 6,454 4,116 3,166 3,366 3,566
EBIT 1 1,338 841 2,614 5,496 3,075 2,150 2,350 2,550
Operating Margin 3.03% 1.95% 5.99% 10.99% 6.55% 5% 5.4% 5.8%
Earnings before Tax (EBT) 1 1,203 1,851 2,892 5,567 3,695 2,680 2,450 2,650
Net income 1 653 1,243 1,853 3,533 2,261 1,650 1,520 1,650
Net margin 1.48% 2.88% 4.25% 7.07% 4.82% 3.84% 3.49% 3.75%
EPS 2 59.80 116.9 178.6 339.0 215.3 153.0 140.9 153.0
Free Cash Flow 1 262 -334 1,437 - 875 1,479 1,237 1,369
FCF margin 0.59% -0.77% 3.3% - 1.87% 3.44% 2.84% 3.11%
FCF Conversion (EBITDA) 12.1% - 40.29% - 21.26% 46.72% 36.75% 38.39%
FCF Conversion (Net income) 40.12% - 77.55% - 38.7% 89.64% 81.38% 82.97%
Dividend per Share 2 46.00 48.00 54.00 64.00 100.0 115.0 120.0 122.0
Announcement Date 5/10/19 5/12/20 5/11/21 5/13/22 5/12/23 - - -
1JPY in Million2JPY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2020 S1 2021 S1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4
Net sales 1 21,933 20,391 12,672 24,693 11,748 13,566 11,566 12,585 24,151 11,727 11,035 10,638 10,687 21,325 10,989 10,686
EBITDA - - - - - - - - - - - - - - - -
EBIT 1 682 712 1,859 3,136 658 1,702 681 1,060 1,741 768 566 249 602 851 592 707
Operating Margin 3.11% 3.49% 14.67% 12.7% 5.6% 12.55% 5.89% 8.42% 7.21% 6.55% 5.13% 2.34% 5.63% 3.99% 5.39% 6.62%
Earnings before Tax (EBT) 404 620 2,007 3,345 649 1,573 748 1,176 1,924 777 994 292 - 1,050 900 -
Net income 1 275 337 1,280 2,125 398 1,010 442 683 1,125 415 721 124 505 629 646 375
Net margin 1.25% 1.65% 10.1% 8.61% 3.39% 7.45% 3.82% 5.43% 4.66% 3.54% 6.53% 1.17% 4.73% 2.95% 5.88% 3.51%
EPS 25.71 32.47 - 204.4 37.94 - 42.32 - 107.5 39.38 - 11.07 - 56.29 58.75 -
Dividend per Share 23.00 24.00 - 28.00 - - - - 32.00 - - - - 40.00 - -
Announcement Date 11/6/19 11/5/20 11/9/21 11/9/21 2/8/22 5/13/22 8/5/22 11/8/22 11/8/22 2/8/23 5/12/23 8/10/23 11/8/23 11/8/23 2/9/24 -
1JPY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 5,332 3,763 5,714 6,575 9,802 9,597 9,650 9,823
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 262 -334 1,437 - 875 1,479 1,237 1,369
ROE (net income / shareholders' equity) 3.4% 6.6% 9.5% 16.1% 9.1% 6.3% 5.8% 6.2%
ROA (Net income/ Total Assets) 5.04% 2.94% 8.27% 15% 8.36% 5.9% 6.3% 6.8%
Assets 1 12,960 42,323 22,416 23,514 27,033 27,966 24,127 24,265
Book Value Per Share 2 1,725 1,776 1,966 2,237 2,362 2,443 2,463 2,494
Cash Flow per Share 134.0 201.0 269.0 429.0 313.0 - - -
Capex 1 1,389 2,235 1,500 2,069 1,211 1,000 1,000 1,000
Capex / Sales 3.15% 5.18% 3.44% 4.14% 2.58% 2.33% 2.3% 2.27%
Announcement Date 5/10/19 5/12/20 5/11/21 5/13/22 5/12/23 - - -
1JPY in Million2JPY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for FALCO HOLDINGS Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
2,231 JPY
Average target price
2,200 JPY
Spread / Average Target
-1.39%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

1st Jan change Capi.
FALCO HOLDINGS CO., LTD. Stock FALCO HOLDINGS Co., Ltd.
+6.85% 151M
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-17.89% 8.25B
RADNET, INC. Stock RadNet, Inc.
+39.20% 3.58B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-39.11% 2.46B
SYNLAB AG Stock SYNLAB AG
-8.06% 2.46B
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
-7.35% 2.38B
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-12.61% 1.81B
FLEURY S.A. Stock Fleury S.A.
-19.01% 1.55B
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-40.66% 1.21B
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+7.56% 1.11B
Medical & Diagnostic Laboratories
  1. Stock Market
  2. Equities
  3. 4671 Stock
  4. Financials FALCO HOLDINGS Co., Ltd.